LATAM Bif Registry

Coronary Bifurcation Lesion Clinical Trial

Official title:

Latin American Registry of Percutaneous Interventions in Coronary Bifurcations

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04471883
• Other study ID #: 00543186
• Status: Not yet recruiting
• Start date: August 15, 2020
• Est. completion date: August 15, 2030

Study information

• Verified date: July 2020
• Source: LATAM Bifurcation Club
• Contact: Marcelo A. Abud, M.D
• Phone: 54 11 33085742
• Email: latambif[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The LATAM Bif Registy is an international and prospective registry of percutaneous coronary interventions (PCI) in coronary bifurcation lesions. The main goal of the study is to investigate the current state and long-term outcomes of PCI in this complex subset of coronary lesions in Latin America.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 5000
• Est. completion date: August 15, 2030
• Est. primary completion date: August 15, 2025
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age >= 18 years

• Any type of bifurcation lesion

• Side-branch reference diameter >= 2 mm

Exclusion Criteria:

• Protected left main disease in patients with previous CABG

• Patients who refuse to be included in the registry

Related Conditions & MeSH terms

• Coronary Bifurcation Lesion

Intervention

Procedure:
• Percutaneous coronary interventions
Percutaneous coronary interventions in coronary bifurcation lesions

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
LATAM Bifurcation Club

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiac Death		5 years
Primary	Myocardial Infarction		5 years
Primary	Target Lesion Revascularization		5 years
Primary	Stent thrombosis		5 years
Primary	Major bleeding		5 years